Mangoceuticals closes registered direct offering priced at 74% premium
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
08:07:13 PM UTC
SquawkNews
Mangoceuticals closed an approximately $500K registered direct offering at $0.75 per unit, a ~74% premium to a referenced $0.43 close. Each unit includes one common share and one warrant; terms and potential dilution are in the Oct. 9, 2026 Form 8-K.Material DetailsContext by AI AnalystThis extends…